Moleculin Biotech Inc. (MBRX)
NASDAQ: MBRX
· Real-Time Price · USD
0.67
0.02 (3.43%)
At close: Aug 15, 2025, 3:59 PM
0.69
2.85%
After-hours: Aug 15, 2025, 07:43 PM EDT
Moleculin Biotech Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -7.64M | -6.44M | -1.88M | -10.59M | -4.32M | -4.97M | -10.27M | -5.61M | -5.98M | -7.92M | -6.77M | -8.61M | -6.78M | -6.87M | -2.83M | -4.38M | -4.24M | -4.45M |
Depreciation & Amortization | 28K | 31K | 31K | 32K | 31K | 32K | 35K | 31K | 31K | 30K | 32K | 32K | 34K | 32K | 34K | 42K | 44K | 44K |
Stock-Based Compensation | 417K | 485K | 427K | 353K | 453K | 493K | 479K | 493K | 513K | 499K | 535K | 699K | 514K | 527K | 556K | 979K | 433K | 405K |
Other Working Capital | n/a | 30K | 1.57M | 811K | -1.15M | -531K | 2.72M | -338K | -1.85M | 682K | 575K | 328K | -2.12K | 713K | 309K | 871K | -1.41M | 1.04M |
Other Non-Cash Items | 1.61M | 650K | -4.71M | 3.57M | -1.7M | -1.35M | 1.19M | 1K | -6K | 843K | -155K | -409K | -6K | -70K | -6K | -7K | -4K | 113K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -59K | -1K | -36K | n/a | n/a | n/a | n/a | n/a | -2.3M | -1.68M | -1.17M | -1.58M |
Change in Working Capital | n/a | 706K | 1.05M | 528K | -418K | -925K | 3.21M | -2.47M | 348K | 526K | -898K | 712K | -1.16M | 1.57M | 283K | 756K | -1.84M | 1.84M |
Operating Cash Flow | -5.58M | -4.56M | -5.08M | -6.11M | -5.95M | -6.72M | -5.41M | -7.55M | -5.13M | -6.02M | -7.26M | -7.58M | -8M | -4.8M | -4.26M | -4.29M | -6.78M | -3.62M |
Capital Expenditures | n/a | n/a | n/a | n/a | -13K | n/a | -81K | -28K | -15K | n/a | -67K | n/a | -61K | -6K | -19K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | -13K | n/a | -81K | -28K | -15K | n/a | -67K | n/a | -61K | -6K | -19K | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | -25 | n/a | n/a | -4K | n/a | n/a | n/a | -11 | -12 | n/a | n/a | -24 | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5.42M | 4K | 4.66M | -1K | -24.98K | n/a | 510K | n/a | -21K | n/a | -12K | -11K | -12K | n/a | 1K | -24K | n/a | 63K |
Financial Cash Flow | 5.42M | 8M | 1K | 4.66M | -25K | n/a | 4.46M | -4K | 49.00 | 141.00 | -12K | -11K | -12K | n/a | -1K | -24K | n/a | 74.75M |
Net Cash Flow | -159K | 3.44M | -5.13M | -1.44M | -5.98M | -6.73M | -1.03M | -7.59M | -5.09M | -5.88M | -7.25M | -7.61M | -8.11M | -4.8M | -4.28M | -4.33M | -6.79M | 71.12M |
Free Cash Flow | -5.58M | -4.56M | -5.08M | -6.11M | -5.96M | -6.72M | -5.49M | -7.58M | -5.14M | -6.02M | -7.32M | -7.58M | -8.06M | -4.81M | -4.28M | -4.29M | -6.78M | -3.62M |